Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02698189
Title A Dose Exploration Study With MK-8628 in Participants With Selected Hematologic Malignancies (MK-8628-005)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.

acute myeloid leukemia

diffuse large B-cell lymphoma



Age Groups: senior | adult
Covered Countries

No variant requirements are available.